Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Claya vs MadeMed

Claya
Graded #268

Lower grade

vs+17.60000000000001
MadeMed
Graded #30

Higher grade

The verdict

MadeMed takes it — 80.4/100 to 62.8/100.

MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes its price at every single dose, so what a titrated dose costs is knowable on day one.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMadeMed +32
42
74
Dose & formulationMadeMed +15
75
90
Clinical oversightMadeMed +2
82
84
Labs & monitoringMadeMed +9
53
62
FulfillmentMadeMed +23
67
90
Contract termsMadeMed +27
61
88
Claya · left barMadeMed · right bar

The numbers

MetricClayaMadeMed
WeighScore62.8/10080.4/100
GradeCB−
Scorecard rank#268#30
Semaglutide$299/mo (compounded)$239/mo quarterly (from $199/mo on 6 months)
Tirzepatide$299/mo (compounded)$399/mo quarterly (from $369/mo on 6 months)
CoverageCoverage not published40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Claya

Graded #268 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage
MadeMed

Graded #30 · B−

Strengths

  • One flat price at every dose, published dose by dose — semaglutide 0.25–2.4mg, tirzepatide 2.5–15mg
  • LegitScript verified, with board-certified physician review and US compounding pharmacies
  • Full refund minus a $39 visit fee if you are not prescribed, stated before checkout
  • Oral semaglutide and oral tirzepatide alongside the injections; free overnight shipping with supplies

Where it loses points

  • The most expensive tirzepatide here at $399/mo quarterly
  • 40 states rather than nationwide
  • No published recurring lab programme
  • Ships one vial every two months, a less flexible cadence than a monthly refill

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard